Time-dependent histamine release from stored human blood products

被引:41
作者
Nielsen, HJ
Edvardsen, L
Vangsgaard, K
Dybkjaer, E
Skov, PS
机构
[1] HVIDOVRE UNIV HOSP,DEPT CLIN IMMUNOL 443,DK-2650 HVIDOVRE,DENMARK
[2] HVIDOVRE UNIV HOSP,SURG IMMUNOL LAB,DK-2650 HVIDOVRE,DENMARK
[3] REFERENCE LAB,COPENHAGEN,DENMARK
关键词
D O I
10.1046/j.1365-2168.1996.02119.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Perioperative tranfusion of whole blood has been shown to amplify trauma-induced immunosuppression, which could be attenuated by perioperative administration of histamine(2) receptor antagonists. Supernatants from different blood products were, therefore, analysed for histamine content during storage. Whole blood (six units), plasma-reduced whole blood (six units), and plasma- and buffy coat-reduced (saline-adenine-glucose-mannitol) (SAGM) blood (six units) from unpaid healthy donors were stored in the blood bank for 35 days at 4 degrees C. Plasma histamine and total cell-bound histamine content at donation, and histamine concentration in samples drawn from the units on days 0, 2, 5, 9, 14, 21, 28 and 35 were analysed with an enzyme-linked immunosorbent assay. Median plasma histamine concentration was 4.8 (range 1.9-14.3) nmol/l (n = 18). Median total cell-bound histamine content was 417.0 (range 176.0-910.0) nmol/l in whole blood and 475.0 (range 360.0-1560.0) nmol/l in plasma-reduced whole blood, while it was undetectable in SAGM blood. Spontaneous histamine release increased in a time-dependent manner from a median of 6.7 (range 2.2-17.4) nmol/l at the time of storage to 175.0 (range 33.0-485.0) nmol/l at day 35 in whole blood, from 18.8 (range 8.2-38.5) to 328.5 (range 224.0-1137.0) nmol/l in plasma-reduced whole blood, and from 0.5 (range 0.5-1.5) to 2.2 (range 1.4-6.9) nmol/l in SAGM blood. These results show spontaneous histamine release during storage of human blood products which contain full amount of leucocytes, and this may play a significant role in detrimental effects of blood transfusion.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 41 条
[1]   SHORT-COURSE CIMETIDINE AND SURVIVAL WITH COLORECTAL-CANCER [J].
ADAMS, WJ ;
MORRIS, DL .
LANCET, 1994, 344 (8939-4) :1768-1769
[2]   CIMETIDINE PRESERVES NONSPECIFIC IMMUNE FUNCTION AFTER COLONIC RESECTION FOR CANCER [J].
ADAMS, WJ ;
MORRIS, DL ;
ROSS, WB ;
LUBOWSKI, DZ ;
KING, DW ;
PETERS, L .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1994, 64 (12) :847-852
[3]   CIMETIDINE INHIBITS IN-VIVO GROWTH OF HUMAN COLON-CANCER AND REVERSES HISTAMINE-STIMULATED IN-VITRO AND IN-VIVO GROWTH [J].
ADAMS, WJ ;
LAWSON, JA ;
MORRIS, DL .
GUT, 1994, 35 (11) :1632-1636
[4]  
BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55
[5]   CANCER MORBIDITY IN BLOOD RECIPIENTS - RESULTS OF A COHORT STUDY [J].
BLOMBERG, J ;
MOLLER, T ;
OLSSON, H ;
ANDERSON, H ;
JONSSON, M .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (15) :2101-2105
[6]   TRANSFUSION AND HOST DEFENSES AGAINST CANCER RECURRENCE AND INFECTION [J].
BLUMBERG, N ;
HEAL, JM .
TRANSFUSION, 1989, 29 (03) :236-245
[7]   AN ASSESSMENT OF PLASMA HISTAMINE CONCENTRATIONS DURING DOCUMENTED ENDOTOXIC-SHOCK [J].
BRACKETT, DJ ;
HAMBURGER, SA ;
LERNER, MR ;
JONES, SB ;
SCHAEFER, CF ;
HENRY, DP ;
WILSON, MF .
AGENTS AND ACTIONS, 1990, 31 (3-4) :263-274
[8]   HISTAMINE-INDUCED INHIBITION OF NEUTROPHIL CHEMOTAXIS AND T-LYMPHOCYTE PROLIFERATION IN MAN [J].
BURY, TB ;
CORHAY, JL ;
RADERMECKER, MF .
ALLERGY, 1992, 47 (06) :624-629
[9]   BLOOD-TRANSFUSIONS AND PROGNOSIS IN COLORECTAL-CANCER [J].
BUSCH, ORC ;
HOP, WCJ ;
VANPAPENDRECHT, MAWH ;
MARQUET, RL ;
JEEKEL, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (19) :1372-1376
[10]   WHITE CELL-REDUCED BLOOD COMPONENTS - SHOULD WE GO WITH THE FLOW [J].
DZIK, WH .
TRANSFUSION, 1991, 31 (09) :789-791